Literature DB >> 34032474

Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.

Andrew D Althouse1, Jennifer E Below2, Brian L Claggett3, Nancy J Cox2, James A de Lemos4, Rahul C Deo3, Sue Duval5, Rory Hachamovitch6, Sanjay Kaul7, Scott W Keith8, Eric Secemsky9, Armando Teixeira-Pinto10, Veronique L Roger11,12.   

Abstract

Statistical analyses are a crucial component of the biomedical research process and are necessary to draw inferences from biomedical research data. The application of sound statistical methodology is a prerequisite for publication in the American Heart Association (AHA) journal portfolio. The objective of this document is to summarize key aspects of statistical reporting that might be most relevant to the authors, reviewers, and readership of AHA journals. The AHA Scientific Publication Committee convened a task force to inventory existing statistical standards for publication in biomedical journals and to identify approaches suitable for the AHA journal portfolio. The experts on the task force were selected by the AHA Scientific Publication Committee, who identified 12 key topics that serve as the section headers for this document. For each topic, the members of the writing group identified relevant references and evaluated them as a resource to make the standards summarized herein. Each section was independently reviewed by an expert reviewer who was not part of the task force. Expert reviewers were also permitted to comment on other sections if they chose. Differences of opinion were adjudicated by consensus. The standards presented in this report are intended to serve as a guide for high-quality reporting of statistical analyses methods and results.

Entities:  

Keywords:  biostatistics

Mesh:

Year:  2021        PMID: 34032474     DOI: 10.1161/CIRCULATIONAHA.121.055393

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team.

Authors:  Romain Chopard; Umberto Campia; Lucas Morin; Karola S Jering; Zaid I Almarzooq; Julia Elizabeth Snyder; Samantha Rizzo; Aaron B Waxman; Samuel Z Goldhaber; Gregory Piazza
Journal:  J Thromb Thrombolysis       Date:  2022-09-03       Impact factor: 5.221

2.  High waist circumference is a risk factor for hypertension in normal-weight or overweight individuals with normal metabolic profiles.

Authors:  Chen Cheng; Jin-Yu Sun; Ying Zhou; Qi-Yang Xie; Li-Yuan Wang; Xiang-Qing Kong; Wei Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-06-23       Impact factor: 2.885

Review 3.  Revisiting Some Useful Statistical Guidelines in Circulation Research in Response to a Changing Landscape.

Authors:  Heather M Highland; Eric R Gamazon; Jennifer E Below
Journal:  Circ Res       Date:  2021-05-25       Impact factor: 23.213

4.  Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.

Authors:  Jill Hahn; Nancy R Cook; Erik K Alexander; Sonia Friedman; Joseph Walter; Vadim Bubes; Gregory Kotler; I-Min Lee; JoAnn E Manson; Karen H Costenbader
Journal:  BMJ       Date:  2022-01-26

Review 5.  Key Factors for Improving Rigor and Reproducibility: Guidelines, Peer Reviews, and Journal Technical Reviews.

Authors:  Hong S Lu; Alan Daugherty
Journal:  Front Cardiovasc Med       Date:  2022-03-09

6.  High waist circumference is a risk factor of new-onset hypertension: Evidence from the China Health and Retirement Longitudinal Study.

Authors:  Jin-Yu Sun; Yong-Xiang Ma; Heng-Li Liu; Qiang Qu; Chen Cheng; Xiang-Qing Kong; Wen-Jun Huang; Wei Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-02-21       Impact factor: 3.738

7.  Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy.

Authors:  G Ian Gallicano; Jiayu Fu; Samiksha Mahapatra; Michael V R Sharma; Conor Dillon; Claire Deng; Maliha Zahid
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-15

8.  Prognostic value of functional capacity after transitional rehabilitation in older patients hospitalized for heart failure.

Authors:  Domenico Scrutinio; Pietro Guida; Roberta Ruggieri; Andrea Passantino
Journal:  J Am Geriatr Soc       Date:  2022-03-10       Impact factor: 7.538

9.  Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis.

Authors:  Romain Chopard; Ida Ehlers Albertsen; Fiona Ecarnot; Sebastien Guth; Matthieu Besutti; Nicolas Falvo; Gregory Piazza; Nicolas Meneveau
Journal:  J Am Heart Assoc       Date:  2022-06-22       Impact factor: 6.106

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.